Advertisement

Clinical Classifications of Breast Cancer

  • Michael H. Torosian
Chapter
Part of the Current Clinical Oncology book series (CCO)

Abstract

Epidemiology, family history, noninherited risk factors, and genetic mutations are important factors in the development of breast cancer. The pathologic characteristics of the primary breast carcinoma, however, are of paramount importance in determining the optimal treatment for breast cancer patients. For defining specific treatment options, breast cancer can be classified into the following clinically relevant categories: invasive/infiltrating carcinoma, ductal carcinoma in situ, microinvasive carcinoma, Paget’s disease, inflammatory carcinoma, and lobular carcinoma in situ. These categories are based on the biologic behavior and prognosis of patients with these distinct types of breast cancer.

Keywords

Breast Cancer Axillary Lymph Node Dissection Lobular Carcinoma Axillary Dissection Sentinel Lymph Node Mapping 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliography

  1. Bodian CA, Perzin KH, Lattes R (1996) Lobular neoplasia: long term risk of breast cancer and relation to other factors. Cancer 78, 1024–1034.PubMedCrossRefGoogle Scholar
  2. Borger J, Kemperman H, Hart A, et al. (1994) Risk factors in breast-conserving therapy. J. Clin. Oncol. 12, 653–660.PubMedGoogle Scholar
  3. Cady B, Stone M, Wayne J (1993) New therapeutic possibilities in primary invasive breast cancer. Ann. Surg. 183, 338.CrossRefGoogle Scholar
  4. Carlson GW, Bostwick J, Styblo TM, et al. (1997) Skin-sparing mastectomy. Oncologic and reconstructive considerations. Ann. Surg. May 225, 570–575.PubMedCrossRefGoogle Scholar
  5. Fisher B, Anderson S, Redmond CK, Wolmark N, Wickerham DL, Cronin WM (1995) Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N. Engl. J. Med. 333, 1456–1461.PubMedCrossRefGoogle Scholar
  6. Fisher B, Costantino J, Redmond C, et al. (1993) Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N. Engl. J. Med. 328, 1581–1586.PubMedCrossRefGoogle Scholar
  7. Giuliano A, Kirgan D, Guenther J, et al. (1994) Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann. Surg. 220, 391.PubMedCrossRefGoogle Scholar
  8. Gump FE, Kinne DW, Schwartz GF (1998) Current treatment for lobular carcinoma in situ (LCIS). Ann. Surg. Oncol. 5, 33–36.PubMedCrossRefGoogle Scholar
  9. Gwin JL, Eisenberg BL, Hoffman JP, Ottery FD, Boraas M, Solin LJ (1993) Incidence of gross and microscopic carcinoma in specimens from patients with breast cancer after re-excision lumpectomy. Ann. Surg. 218, 729–734.PubMedCrossRefGoogle Scholar
  10. Holland R, Peterse JL, Millis RR, et al. (1994) Ductal carcinoma in situ: a proposal for a new classification. Semin. Diagn. Pathol. 11, 167.PubMedGoogle Scholar
  11. Hunter MA, McFall TA, Hehr KA (1996) Breast-conserving surgery for primary breast cancer: necessity for surgical clips to define the tumor bed for radiation planning. Radiology 200, 281–282.PubMedGoogle Scholar
  12. Jacobson JA, Danfort DN, Cowan KH, et al. (1995) Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N. Engl. J. Med. 332, 907–911.PubMedCrossRefGoogle Scholar
  13. Lagios MD (1990) Duct carcinoma in situ: pathology and treatment. Surg. Clin. North Am. 70, 853–871.PubMedGoogle Scholar
  14. Lagios MD, Westdahl PR, Rose MR, et al. (1984) Paget’s disease of the nipple: alternative management in cases without or with minimal extent of underlying breast carcinoma. Cancer 54, 545.PubMedCrossRefGoogle Scholar
  15. Petrek JA, Blackwood MM (1995) Axillary dissection: current practice and technology. Curr. Probl. Surg. 32, 256–323.CrossRefGoogle Scholar
  16. Schafter P, Alberto P, Formi M, et al. (1987) Surgery as a part of a combined modality approach for inflammatory breast carcinoma. Cancer 59, 1063.CrossRefGoogle Scholar
  17. Schnitt SJ, Abner A, Gelman R, et al. (1994) The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy. Cancer 74, 1746–1751.PubMedCrossRefGoogle Scholar
  18. Silverstein MJ, Poller DN, Waisman JR, et al. (1995) Prognostic classification of breast ductal carcinoma in situ. Lancet 345, 1154–1157.PubMedCrossRefGoogle Scholar
  19. Smitt MC, Nowels KW, Zdeblick MJ, et al. (1995) The importance of the lumpectomy surgical margin status in long term results of breast conservation. Cancer 76, 259–267.PubMedCrossRefGoogle Scholar
  20. Solin LJ, Yeh IT, Kurt J, et al. (1993) Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation: correlation of pathologic parameters with outcome of treatment. Cancer 71, 2532–2542.PubMedCrossRefGoogle Scholar
  21. Yeatman TJ, Cantor AB, Smith TJ, et al. (1995) Tumor biology of infiltrating lobular carcinoma. Implications for management. Ann. Surg. 222, 549–561.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • Michael H. Torosian

There are no affiliations available

Personalised recommendations